Yoga for Patients With Epilepsy

Epilepsy Clinical Trial

Official title:

Is Yoga Safe for Patients With Epilepsy?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00179452
• Other study ID #: 2003P000337
• Status: Completed
• Phase: N/A
• First received: September 13, 2005
• Last updated: March 9, 2017
• Start date: October 2003
• Est. completion date: October 2008

Study information

• Verified date: March 2017
• Source: Beth Israel Deaconess Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To establish the safety and feasibility of having patients with epilepsy perform yoga.

Description:

Subjects will keep logs of seizure frequency prior to, during, and following training in a yoga regimen. Instruction in the yoga regimen will occur at BIDMC, and home practice following classroom instruction will occur as part of the study. Side effects, changes in seizure frequency, and quality of life assessments will be performed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: October 2008
• Est. primary completion date: October 2008
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

1. Must be able to give full informed consent.

2. Must have one or more of the following seizure types: simple partial, complex partial, or secondarily generalized.

3. Age 18-64.

4. Must have 4-20 during the baseline phase.

5. Must have medical clearance from their primary care giver sufficient to allow for participation in yoga exercises.

6. Must be stable enough to allow for all anticonvulsant levels to remain constant for the duration of the study.

Exclusion Criteria:

1. Having primary generalized epilepsy or atonic seizures.

2. Having a history of status epilepticus in the past two years.

3. Any medical problem that would preclude participation in a yoga class.

4. Nonepileptic or psychogenic seizures.

5. Pregnancy.

Related Conditions & MeSH terms

• Epilepsy

Intervention

Behavioral:
• Yoga

Locations

Country	Name	City	State
United States	Beth Israel Deaconess Medical Center	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Beth Israel Deaconess Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement in quality of life assessments.		3 months
Primary	Improvement in mood.		3 months
Secondary	Improvement in seizure control.		3 months